Trial Profile
A Study to Evaluate the Safety and Pharmacokinetics of Single and Multiple Oral Doses of MK-8742 in Healthy Male Subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 04 Dec 2015
Price :
$35
*
At a glance
- Drugs Elbasvir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Pharmacokinetics
- 04 Dec 2015 New trial record